Racial and ethnic disparities in pancreatic cancer treatment and survival persist, with minority groups experiencing lower ...
Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.
The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...
Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients with undetectable PSA levels.
A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...
ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...
For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has emerged over the past two decades.
Accurate assessment of partial pathological response rate (ppRR) to neoadjuvant chemotherapy (NAT) is critical for assessing the efficacy of therapy and for optimal clinical management. Because of a ...
The monarch delivered a pre-recorded television message as part of Channel 4’s Stand Up To Cancer night on Dec. 12 Max Mumby/Indigo/Getty King Charles shared a pre-taped personal message ahead of ...
In men with hormone-sensitive metachronous oligometastatic prostate cancer, the use of stereotactic body radiotherapy (SBRT) commonly delayed the need for long-term ADT and provided durable disease ...
New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the chances of patients’ survival. The key? Detecting tiny lung nodules when doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback